About From Lab to Field: On-Site Saliva Drug Testing and The Journey of COSMAS BIOSCIENCE
This seven-part series follows COSMAS BIOSCIENCE from the 2021 THC research paper to AI-assisted R&D of D-Free. Explore Grok selection, literature and patent review, fluid and optical simulation, Bayesian optimization, image QC, optical readout, validation planning, and the road ahead. Grok is a development tool, not part of the device. D-Free remains in development; validation and regulatory reviews are ahead. Produced by COSMAS BIOSCIENCE with AI-generated voices. Not sponsored by xAI.
EP 7. What AI-Assisted R&D Means for the Road Ahead
North American need: approximately 69,000 U.S. overdose deaths (CDC provisional data, 12 months ending January 2026) and 7,146 Canadian opioid deaths (PHAC, 2024).
The team’s internal estimate: over 35% improvement in cost and development efficiency. This estimate has not been audited.
A global launch is targeted around 2027, subject to approval, alongside the KPEX 2026 exhibition and the Hong-ik In-gan mission.
3 Nov 2026
EP 6. From Light Signal to Number
A compact optical reader and app software comparing signals with calibrated cutoffs.
Grok supports comparison of signal-processing methods. The final algorithm is selected by measurement and frozen.
Requirement–design–test–result traceability and draft validation plans.
FDA, Health Canada, and MFDS reviews are still ahead. Screening results are handled as sensitive personal data.
21 Oct 2026
EP 5. Global Horizon: Public Safety Impact & 2027 Roadmap
Highlights the social value of non-invasive saliva testing across traffic enforcement and corrections, alongside international milestones including CES participation and 2027 US agency validation goals.
21 Oct 2026
EP 4. Evolution of Multiplex AI Diagnostics: D-FREE
Explores the D-FREE system, a multi-channel paper chip and optical reader powered by on-device AI that simultaneously screens for five major illicit substances: THC, methamphetamine, morphine, oxycodone, and MDMA.
21 Oct 2026
EP 3. Bridge to Reality: Founding COSMAS BIOSCIENCE
Chronicles the founding of COSMAS BIOSCIENCE in 2024 by Dr. Hojeong Yu, transitioning point-of-care bioengineering from academic proof-of-concept into real-world public safety infrastructure.
21 Oct 2026
EP 2. The Breakthrough: EPOCH System & Science Translational Medicine
Examines the 2021 Science Translational Medicine paper introducing EPOCH. Discover how radial membrane flow and optical transmission enabled quantitative THC detection down to 0.17 ng/mL within 5 minutes in human trials.
Source: Yu et al., Science Translational Medicine (2021). https://doi.org/10.1126/scitranslmed.abe2352
21 Oct 2026
EP 1. The Challenge: Rethinking Roadside Drug Testing
Unpacks the limitations of conventional urine test strips and laboratory GC-MS, explaining why rapid, quantitative oral-fluid screening became an urgent necessity for law enforcement and public health.
Contact From Lab to Field: On-Site Saliva Drug Testing and The Journey of COSMAS BIOSCIENCE
Guest appearances
Does not typically book guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of From Lab to Field: On-Site Saliva Drug Testing and The Journey of COSMAS BIOSCIENCE?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
